2025-521240-37-00
CTIS ↗
Placebo for SPT-300
Major Depressive Disorder (MDD), with or without Anxious Distress
pharma · Major Depressive Disorder (MDD), with or without Anxious Distress · Major Depressive Disorder (MDD) · SPTX
Seaport Therapeutics
Seaport Therapeutics trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.
Boston, USA HQ
68 Employees
Public company Type
SPTX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Boston, USA
- Employees
- 68
- Programs
- 3
- Drugs
- 3
- Patents
- 1
Seaport Therapeutics clinical trials
Registry index of 4 ClinicalTrials.gov studies linked to Seaport Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Seaport Therapeutics trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Seaport Therapeutics.
Trial registry
-
- 2025-522347-18-00CTIS ↗
SPT-300-2024-204
Major Depressive Disorder (MDD), with or without Anxious Distress
-
CT.gov ↗ -
CT.gov ↗